OMNIAB, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.6 USD | +0.88% |
|
+3.84% | -25.45% |
| 25/03 | OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing | MT |
| 21/03 | Sector Update: Health Care Stocks Gain Pre-Bell Thursday | MT |
Chart calendar OmniAb, Inc.
f9c10647007d6005ffcc2a52d26b885b._9vslGATW4Y6s1s25XRzcmX16anrCjcOusyhTRn7m_A.iY2W5lhrEsttgR0BjCYWGzKqg5mRZVQ74KvGOy-695WNmZ7fEVsqzGPjDg~339e5dce16daa116beceb9c0a39a3765
Upcoming events on OmniAb, Inc.
Past events on OmniAb, Inc.
| 21/03/2024 02:00 am | Q4 2023 Earnings Call |
| 21/03/2024 01:35 am | Q4 2023 Earnings Release |
| 12/03/2024 | Leerink Partners Global Biopharma Conference |
| 04/03/2024 09:40 pm | TD Cowen Health Care Conference |
| 16/11/2023 | Craig-Hallum Alpha Select Conference |
| 15/11/2023 06:30 pm | Stifel Healthcare Conference |
| 09/11/2023 09:30 pm | Q3 2023 Earnings Call |
| 09/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 26/09/2023 | Cantor Global Healthcare Conference |
| 12/09/2023 06:30 pm | H.C. Wainwright Global Investment Conference |
| 11/08/2023 02:00 am | Q2 2023 Earnings Call |
| 11/08/2023 01:35 am | Q2 2023 Earnings Release |
| 23/06/2023 08:30 pm | Annual General Meeting |
| 31/05/2023 | Craig-Hallum Institutional Investor Conference |
| 24/05/2023 | B. Riley Securities Institutional Investor Conference |
| 23/05/2023 | Benchmark Healthcare House Call Virtual Conference |
| 17/05/2023 10:40 pm | PEGS Boston Conference |
| 11/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 11/05/2023 04:30 pm | Q1 2023 Earnings Release |
| 10/05/2023 | EF Hutton Global Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 59,1 50,9 16.09% | 34,2 37,8 -9.72% | 31,7 |
|
EBITDA Million USD | Released Forecast Spread | -13,6 -1,22 -1014.59% | -55,9 -46,3 -20.57% | -57,4 |
|
EBIT Million USD | Released Forecast Spread | -26,6 -32,0 16.63% | -69,4 -64,7 -7.24% | -73,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,1 -49,2 47.01% | -64,4 -59,9 -7.41% | -69,3 |
|
Net income Million USD | Released Forecast Spread | -22,3 -37,5 40.44% | -50,6 -50,9 0.53% | -60,1 |
|
EPS USD | Released Forecast Spread | -0,26 -0,37 30.11% | -0,51 -0,51 -0.74% | -0,59 |
| Announcement Date | 30/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,91 | 35,3 24,7 42.89% | 16,9 18,8 -10.23% | 6,95 11,9 -41.69% | 5,48 10,3 -46.98% | 4,82 7,46 -35.4% | 5,87 | 6,92 | 8,79 | 10,3 |
|
EBITDA Million USD | Released Forecast Spread | -5,08 -8,50 40.19% | -16,1 -13,7 -17.22% | -16,9 -16,4 -3.47% | -17,8 -12,7 -40.6% | -15,8 | -16,1 | -14,3 | -11,2 | ||
|
EBIT Million USD | Released Forecast Spread | 9,05 3,47 160.48% | -8,45 -5,43 -55.65% | -19,4 -12,4 -57.2% | -20,3 -15,5 -30.68% | -21,2 -18,1 -16.92% | -19,5 | -19,3 | -18,0 | -16,6 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9,64 -6,21 255.19% | -7,13 5,30 -234.44% | -18,2 -12,1 -50.22% | -19,0 -14,7 -29.2% | -20,0 -17,1 -17.46% | -18,5 | -18,2 | -17,0 | -15,7 | |
|
Net income Million USD | Released Forecast Spread | -12,6 | 6,82 -1,10 721.7% | -6,10 5,67 -207.65% | -14,7 -10,9 -35% | -15,7 -14,2 -10.68% | -14,1 -15,7 10.33% | -16,3 | -15,8 | -14,6 | -13,5 |
|
EPS USD | Released Forecast Spread | 0,07 -0,02 450% | -0,06 0,06 -205.88% | -0,15 -0,11 -36.36% | -0,16 -0,14 -13.13% | -0,14 -0,15 7.44% | -0,16 | -0,15 | -0,14 | -0,13 | |
| Announcement Date | 14/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 20/03/24 | - | - | - | - |
More events
Past sector events for OmniAb, Inc.
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OABI Stock
- Calendar OmniAb, Inc.
